JACKSONVILLE, Fla. & NASHVILLE, Tenn.--(BUSINESS WIRE)--Availity ®, the nation’s leading real-time health information network, and Concert ®, the leading provider of clinical content and payment ...

Collaboration delivers scalable infrastructure to help payers and providers prepare for new federal interoperability ...

Powered by agentic AI, Galaxy UM orchestrates workflows across the prior authorization process, from intake to decision-making and communication. The platform uses advanced natural language processing ...

March 18, 2026 / ZeOmega, the industry's leading population health management organization, today announced it was listed in Gartner's 2026 Market Guide for Intelligent Prior Authorization. The report ...

The MarketWatch News Department was not involved in the creation of this content. MENLO PARK, Calif., Dec. 18, 2025 /PRNewswire/ -- Develop Health, an AI-powered eligibility and prior authorization ...

Columbus, Ohio-based PriorAuthNow, maker of an electronic prior authorization platform, has closed a $10.5 million Series A funding round. The investment was led by Atlanta-based BIP Capital, with ...

HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--Voluware formally reintroduces itself today as Valer®, taking the same brand name as its popular solution for streamlining prior authorizations and referral ...

MENLO PARK, Calif., Dec. 18, 2025 /PRNewswire/ -- Develop Health, an AI-powered eligibility and prior authorization automation platform, today announced its integration with athenaOne, bringing its ...

PHILADELPHIA, PA, UNITED STATES, January 27, 2026 /EINPresswire.com/ — Ethermed, an AI-powered healthcare automation company, today announced a partnership with ...

CUPERTINO, CA / ACCESS Newswire / March 31, 2026 / Infinx Healthcare, a technology-enabled revenue cycle solutions provider, announced today that it was named as a Representative Vendor in the Gartner ...

Please provide your email address to receive an email when new articles are posted on . An electronic health record tool has demonstrated the potential to automate the selection of biosimilars.

Organizations that treat claims technology as discretionary spending will continue losing a significant percentage of their ...